FTSE 100
8.604,98
PKT
+50,18
PKT
+0,59
%
Werbung
Analysen zu FTSE 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 28.05.15 | Standard Chartered Underweight | Morgan Stanley | |
| 28.05.15 | Imperial Brands Reduce | Nomura | |
| 28.05.15 | Prudential Neutral | Nomura | |
| 28.05.15 | BP buy | Deutsche Bank AG | |
| 28.05.15 | Shell (ex Royal Dutch Shell) Hold | Deutsche Bank AG | |
| 28.05.15 | London Stock Exchange (LSE) buy | Citigroup Corp. | |
| 28.05.15 | HSBC Neutral | UBS AG | |
| 27.05.15 | Diageo market-perform | Bernstein Research | |
| 27.05.15 | AstraZeneca buy | Citigroup Corp. | |
| 27.05.15 | Glencore Neutral | Citigroup Corp. | |
| 27.05.15 | Rio Tinto Neutral | Citigroup Corp. | |
| 27.05.15 | Glencore Equal-Weight | Morgan Stanley | |
| 27.05.15 | AstraZeneca buy | UBS AG | |
| 26.05.15 | GSK verkaufen | JP Morgan Chase & Co. | |
| 26.05.15 | AstraZeneca Hold | Deutsche Bank AG | |
| 26.05.15 | Vodafone Group buy | Deutsche Bank AG | |
| 26.05.15 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 26.05.15 | BP Neutral | UBS AG | |
| 26.05.15 | Vodafone Group buy | UBS AG | |
| 26.05.15 | Glencore Underweight | JP Morgan Chase & Co. | |
| 26.05.15 | AstraZeneca buy | UBS AG | |
| 26.05.15 | AstraZeneca Underweight | Barclays Capital | |
| 22.05.15 | GSK Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.05.15 | BP Neutral | JP Morgan Chase & Co. | |
| 22.05.15 | Lloyds Banking Group buy | Deutsche Bank AG | |
| 22.05.15 | Barclays buy | Deutsche Bank AG | |
| 22.05.15 | Lloyds Banking Group buy | Deutsche Bank AG | |
| 22.05.15 | Barclays buy | Deutsche Bank AG | |
| 22.05.15 | Vodafone Group buy | Deutsche Bank AG | |
| 22.05.15 | Vodafone Group buy | Goldman Sachs Group Inc. | |
| 22.05.15 | Lloyds Banking Group Neutral | Goldman Sachs Group Inc. | |
| 21.05.15 | GSK Hold | Jefferies & Company Inc. | |
| 21.05.15 | AstraZeneca buy | Jefferies & Company Inc. | |
| 21.05.15 | Rio Tinto Neutral | Citigroup Corp. | |
| 21.05.15 | Vodafone Group buy | Citigroup Corp. | |
| 21.05.15 | Barclays overweight | JP Morgan Chase & Co. | |
| 21.05.15 | AstraZeneca buy | Citigroup Corp. | |
| 21.05.15 | GSK neutral | Citigroup Corp. | |
| 21.05.15 | Vodafone Group Neutral | Nomura | |
| 20.05.15 | Vodafone Group overweight | Barclays Capital |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.